# Arteriovenous Fistulae: Drug-eluting Balloon Angioplasty

> **NCT02913274** · NA · TERMINATED · sponsor: **Rennes University Hospital** · enrollment: 115 (actual)

## Conditions studied

- Stenosis of Arteriovenous Dialysis Fistula

## Interventions

- **DEVICE:** Paclitaxel (Taxol) eluting angioplasty balloon
- **DEVICE:** high-pressure angioplasty balloon
- **DEVICE:** low-pressure balloon

## Key facts

- **NCT ID:** NCT02913274
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-03-20
- **Primary completion:** 2020-04-21
- **Final completion:** 2020-04-21
- **Target enrollment:** 115 (ACTUAL)
- **Why stopped:** The study was temporarily suspended after a meta-analysis suggesting higher mortality risks among patients treated with Paclitaxel-coated balloons. When the study was open again, no new patient accepted to be included. The study stopped on 18AUG2023.
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02913274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02913274, "Arteriovenous Fistulae: Drug-eluting Balloon Angioplasty". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02913274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*